Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Myositis-associated interstitial lung disease: a comprehensive approach to diagnosis and management.

Clinical and experimental rheumatology - 1 Feb 2022

Hallowell Robert W, Paik Julie J

Abstract excerpt

Interstitial lung disease (ILD) frequently complicates the inflammatory myopathies and at times is the most prominent clinical feature. Over the years, there has been a growing recognition for the strong association between seropositivity of several myositis-specific antibodies (MSAs) and lung involvement. Growing literature suggests that individual MSAs may influence the risk of developing ILD and are associated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoantibodies
Share to Lung Diseases, Interstitial
Share to Myositis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 33769263
DOI: 10.55563/clinexprheumatol/brvl1v
PMCID: PMC8855729

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Myositis-associated interstitial lung disease: a comprehensive approach to diagnosis and management.PMID 33769263Read ↗

Classification of myositis.Semantic proximity Read ↗

Integrated classification of inflammatory myopathiesSemantic proximity Read ↗

Interstitial lung disease in inflammatory myopathies: clinical phenotypes and prognosis.Semantic proximity Read ↗

Shaping the landscape of interstitial lung disease in idiopathic inflammatory myopathies: state of the art, evidence gaps and a need for clinical trials.Semantic proximity Read ↗

Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies.Semantic proximity Read ↗

Idiopathic inflammatory myopathies: diagnostic criteria, classification and epidemiological features.Semantic proximity Read ↗

Clinical significance of myositis-specific autoantibodiesSemantic proximity Read ↗

The clinical phenotype of patients positive for antibodies to myositis and myositis-related disorders.Semantic proximity Read ↗

Juvenile idiopathic inflammatory myositis: an update on pathophysiology and clinical care.Semantic proximity Read ↗

Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies.Semantic proximity Read ↗

The differential role of SSa/SSb and Ro52 antibodies in defining clinical phenotypes in idiopathic inflammatory myopathies.Semantic proximity Read ↗

Autoantibodies in myositis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.